InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.334
-0.046 (-3.34%)
Nov 20, 2024, 4:00 PM EST - Market closed
InterCure Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for InterCure.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for InterCure.
Recommendation Trends
Rating | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 3 | 3 | 3 | 3 | 3 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 9 | 9 | 9 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
TD Cowen | TD Cowen | Buy Maintains $10 → $5 | Buy | Maintains | $10 → $5 | +274.84% | Apr 12, 2023 |
Barclays | Barclays | Hold Initiates $40 | Hold | Initiates | $40 | +2,898.73% | Dec 11, 2017 |
Credit Suisse | Credit Suisse | Buy Maintains $68 → $54 | Buy | Maintains | $68 → $54 | +3,948.28% | Nov 14, 2017 |
Keybanc | Keybanc | Buy Maintains $68 → $46 | Buy | Maintains | $68 → $46 | +3,348.53% | Nov 13, 2017 |
Baird | Baird | Buy Maintains $67 → $46 | Buy | Maintains | $67 → $46 | +3,348.53% | Nov 10, 2017 |
Financial Forecast
Revenue This Year
290.70M
from 355.55M
Decreased by -18.24%
Revenue Next Year
404.94M
from 290.70M
Increased by 39.30%
EPS This Year
-0.04
from -1.36
EPS Next Year
0.59
from -0.04
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 299.3M | 416.9M | 590.9M |
Avg | 290.7M | 404.9M | 574.0M |
Low | 279.3M | 389.1M | 551.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | -15.8% | 43.4% | 45.9% |
Avg | -18.2% | 39.3% | 41.7% |
Low | -21.4% | 33.8% | 36.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.04 | 0.61 | 1.75 |
Avg | -0.04 | 0.59 | 1.70 |
Low | -0.04 | 0.57 | 1.64 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | 196.4% |
Avg | - | - | 187.9% |
Low | - | - | 176.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.